The results obtained by the researchers in the xenograft tumor model and HCT116 cell line showed that this nanoparticle with multiple targeting functions could deliver TRAIL to the tumor area, inhibit tumor cell growth, promote apoptosis, and reduce the proportion of CSCs. The gene discussed is TNFSF10; the disease is neoplasm.